Outcomes of de novo belatacept-based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization.

NephrologyVolume 27, Issue 12 p. 1006-1007 LETTER TO THE EDITOR Outcomes of de novo belatacept-based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization Gregory Petrossian, Corresponding Author Gregory Petrossian [email protected] orcid.org/0000-0002-1585-5779 Section of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, New York, USA Correspondence Gregory Petrossian, Section of Renal and Pancreatic Transplant Services, Albany Medical Center, 43 New Scotland Avenue, Albany, NY 12208, USA. Email: [email protected]Search for more papers by this authorJorge Ortiz, Jorge Ortiz Section of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, New York, USASearch for more papers by this authorAlejandro Chiodo Ortiz, Alejandro Chiodo Ortiz Section of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, New York, USASearch for more papers by this authorNaoru Koizumi, Naoru Koizumi Schar School of Policy and Government, George Mason University, Fairfax, Virginia, USASearch for more papers by this authorRobert Plews, Robert Plews Section of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, New York, USASearch for more papers by this author Gregory Petrossian, Corresponding Author Gregory Petrossian [email protected] orcid.org/0000-0002-1585-5779 Section of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, New York, USA Correspondence Gregory Petrossian, Section of Renal and Pancreatic Transplant Services, Albany Medical Center, 43 New Scotland Avenue, Albany, NY 12208, USA. Email: [email protected]Search for more papers by this authorJorge Ortiz, Jorge Ortiz Section of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, New York, USASearch for more papers by this authorAlejandro Chiodo Ortiz, Alejandro Chiodo Ortiz Section of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, New York, USASearch for more papers by this authorNaoru Koizumi, Naoru Koizumi Schar School of Policy and Government, George Mason University, Fairfax, Virginia, USASearch for more papers by this authorRobert Plews, Robert Plews Section of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, New York, USASearch for more papers by this author First published: 17 October 2022 https://doi.org/10.1111/nep.14120Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume27, Issue12December 2022Pages 1006-1007 RelatedInformation